272 related articles for article (PubMed ID: 20398022)
21. Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: extended report.
Catrina AI; Trollmo C; af Klint E; Engstrom M; Lampa J; Hermansson Y; Klareskog L; Ulfgren AK
Arthritis Rheum; 2005 Jan; 52(1):61-72. PubMed ID: 15641091
[TBL] [Abstract][Full Text] [Related]
22. Biologics in rheumatoid arthritis.
Sharma PK; Hota D; Pandhi P
J Assoc Physicians India; 2004 Mar; 52():231-6. PubMed ID: 15636315
[TBL] [Abstract][Full Text] [Related]
23. Infliximab and insulin resistance.
Ursini F; Naty S; Grembiale RD
Autoimmun Rev; 2010 Jun; 9(8):536-9. PubMed ID: 20060507
[TBL] [Abstract][Full Text] [Related]
24. [Treatment of rheumatoid arthritis by inhibition of tumor necrosis factor with infliximab or etanercept].
Tijhuis GJ; van de Putte LB; Breedveld FC
Ned Tijdschr Geneeskd; 2001 Sep; 145(39):1880-5. PubMed ID: 11605312
[TBL] [Abstract][Full Text] [Related]
25. Effective use of TNF antagonists.
Yocum D
Arthritis Res Ther; 2004; 6 Suppl 2(Suppl 2):S24-30. PubMed ID: 15228618
[TBL] [Abstract][Full Text] [Related]
26. Anti-inflammatory therapy with tumour necrosis factor alpha inhibitors improves high-density lipoprotein cholesterol antioxidative capacity in rheumatoid arthritis patients.
Popa C; van Tits LJ; Barrera P; Lemmers HL; van den Hoogen FH; van Riel PL; Radstake TR; Netea MG; Roest M; Stalenhoef AF
Ann Rheum Dis; 2009 Jun; 68(6):868-72. PubMed ID: 18635596
[TBL] [Abstract][Full Text] [Related]
27. Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients.
Wolfe F; Michaud K
Arthritis Rheum; 2004 Jun; 50(6):1740-51. PubMed ID: 15188349
[TBL] [Abstract][Full Text] [Related]
28. Tolerance and effectiveness of anti-tumor necrosis factor alpha therapies in elderly patients with rheumatoid arthritis: a population-based cohort study.
Genevay S; Finckh A; Ciurea A; Chamot AM; Kyburz D; Gabay C;
Arthritis Rheum; 2007 May; 57(4):679-85. PubMed ID: 17471545
[TBL] [Abstract][Full Text] [Related]
29. Influence of anti-TNF-alpha infliximab therapy on adhesion molecules associated with atherogenesis in patients with rheumatoid arthritis.
Gonzalez-Gay MA; Garcia-Unzueta MT; De Matias JM; Gonzalez-Juanatey C; Garcia-Porrua C; Sanchez-Andrade A; Martin J; Llorca J
Clin Exp Rheumatol; 2006; 24(4):373-9. PubMed ID: 16956426
[TBL] [Abstract][Full Text] [Related]
30. Cardiovascular disease in rheumatoid arthritis.
Gonzalez-Gay MA; Gonzalez-Juanatey C; Miranda-Filloy JA; Garcia-Porrua C; Llorca J; Martin J
Biomed Pharmacother; 2006 Dec; 60(10):673-7. PubMed ID: 17049201
[TBL] [Abstract][Full Text] [Related]
31. TNF inhibitors - new and old agents for rheumatoid arthritis.
Simsek I
Bull NYU Hosp Jt Dis; 2010; 68(3):204-10. PubMed ID: 20969553
[TBL] [Abstract][Full Text] [Related]
32. TNF-alpha antagonism and cancer risk in rheumatoid arthritis: is continued vigilance warranted?
Park HJ; Ranganathan P
Discov Med; 2012 Mar; 13(70):229-34. PubMed ID: 22463799
[TBL] [Abstract][Full Text] [Related]
33. Visfatin is not associated with inflammation or metabolic syndrome in patients with severe rheumatoid arthritis undergoing anti-TNF-alpha therapy.
Gonzalez-Gay MA; Vazquez-Rodriguez TR; Garcia-Unzueta MT; Berja A; Miranda-Filloy JA; de Matias JM; Gonzalez-Juanatey C; Llorca J
Clin Exp Rheumatol; 2010; 28(1):56-62. PubMed ID: 20346239
[TBL] [Abstract][Full Text] [Related]
34. Insulin resistance in patients with rheumatoid arthritis: effect of anti-TNFalpha therapy.
Rosenvinge A; Krogh-Madsen R; Baslund B; Pedersen BK
Scand J Rheumatol; 2007; 36(2):91-6. PubMed ID: 17476613
[TBL] [Abstract][Full Text] [Related]
35. Short-term effect of anti-TNF-alpha therapy on nitric oxide production in patients with severe rheumatoid arthritis.
Gonzalez-Gay MA; Garcia-Unzueta MT; Berja A; Vazquez-Rodriguez TR; Miranda-Filloy JA; Gonzalez-Juanatey C; de Matias JM; Martin J; Dessein PH; Llorca J
Clin Exp Rheumatol; 2009; 27(3):452-8. PubMed ID: 19604438
[TBL] [Abstract][Full Text] [Related]
36. TNF inhibitors for rheumatoid arthritis - a year in review.
Simsek I
Bull NYU Hosp Jt Dis; 2011; 69(3):220-4. PubMed ID: 22035432
[TBL] [Abstract][Full Text] [Related]
37. The effect of TNF-alpha blocking therapy on lipid levels in rheumatoid arthritis: a meta-analysis.
van Sijl AM; Peters MJ; Knol DL; de Vet RH; Sattar N; Dijkmans BA; Smulders YM; Nurmohamed MT
Semin Arthritis Rheum; 2011 Dec; 41(3):393-400. PubMed ID: 21665247
[TBL] [Abstract][Full Text] [Related]
38. Apoptosis as a mechanism of action of tumor necrosis factor antagonists in rheumatoid arthritis.
Makrygiannakis D; Catrina AI
J Rheumatol; 2012 Apr; 39(4):679-85. PubMed ID: 22422498
[TBL] [Abstract][Full Text] [Related]
39. Pharmacogenomics of tumor necrosis factor antagonists in rheumatoid arthritis.
Ranganathan P
Pharmacogenomics; 2005 Jul; 6(5):481-90. PubMed ID: 16013998
[TBL] [Abstract][Full Text] [Related]
40. Dermatological conditions during TNF-alpha-blocking therapy in patients with rheumatoid arthritis: a prospective study.
Flendrie M; Vissers WH; Creemers MC; de Jong EM; van de Kerkhof PC; van Riel PL
Arthritis Res Ther; 2005; 7(3):R666-76. PubMed ID: 15899052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
